EMBO Mol. Medicine

#OpenAccess journal dedicated to high quality research at the interface between clinical & basic science. @EMBOPress, tweets from journal editors

[EMBO Mol. Medicine @EmboMolMed]

EMBO Molecular Medicine is on Bluesky!
@embomolmed.org

➡️ https://t.co/yxirRsv0pb

See you there!

[EMBO Mol. Medicine @EmboMolMed]

EMBO Molecular Medicine is on Bluesky!
➡️ https://t.co/yxirRsv0pb
See you there!

[EMBO Mol. Medicine @EmboMolMed]

EMBO Molecular Medicine is on Bluesky!
@embomolmed.org

➡️ https://t.co/yxirRsv0pb

See you there!

[EMBO Mol. Medicine @EmboMolMed]

EMBO Mol. Med. shares news and updates on the alternative platform now. We'd love to stay connected!
Find us there: https://t.co/NFNc1jo0yh

[EMBO Mol. Medicine @EmboMolMed]

EMBO Molecular Medicine is on Bluesky!
➡️ https://t.co/yxirRsv0pb
See you there!

[EMBO Mol. Medicine @EmboMolMed]

EMBO Mol. Med. shares news and updates on the alternative platform now. We'd love to stay connected!
Find us there: https://t.co/NFNc1jo0yh

[Matthew S. Alexander @Matt_Muscle_Guy]

Excited to share this new collaborative @EmboMolMed work from my lab @ChildrensAL & @jdowling007 labs. Work highlights efforts to generate a new animal model for X-linked myopathy with excessive autophagy (XMEA) and perform corrective drug screening. 1/n https://t.co/hRgrJQLfId

[Intestinal Cell News @Intestinal_Cell]

🧬 Dr. Abdel-Majid Khatib's team at @BRIC_Bordeaux explored the therapeutic potential of targeting proapelin cleavage sites in metastatic #CRC by introducing apelin-dm, a variant resulting from alteration in proapelin cleavage sites.

@EmboMolMed | https://t.co/zZtszwFjtq

[EMBO Mol. Medicine @EmboMolMed]

Repression of #apelin Furin cleavage sites provides antimetastatic strategy in #ColorectalCancer

By B. Demoures, G. Siegfried, AM Khatib & colleagues @Inserm

➡️https://t.co/gaoExYs1DR

[EMBO Mol. Medicine @EmboMolMed]

Portimine A #toxin causes #SkinInflammation through ZAKα-dependent #NLRP1 inflammasome activation

By P. Brehmer, F. Roca, F. Zhong, J. Common, E. Meunier, P. Hess & colleagues

🗞️https://t.co/axB3TLUCcD

[EMBO Mol. Medicine @EmboMolMed]

➡️Read this review by A. Bleckmann & colleagues that provides a comparison of in vivo, ex vivo, and in vitro models for studying #tumor - #microbiome interactions in early-onset #ColorectalCancer

🗞️https://t.co/q4JUmUjZKT

[EMBO Mol. Medicine @EmboMolMed]

📢New issue online!
The cover highlights the study by M Breßer, K D Siemens, R Schneider et al. on the role of reactive resident #macrophages in surgery-induced #GutInflammation & resulting enteric #neurodegeneration.

Image by R. Schneider & colleagues

📰https://t.co/PQlhA15fFK

[EMBO Reports @emboreports]

Are you attending the #EMBOmetabolicDiseases meeting in beautiful Torremolinos? So is our editor Deniz Senyilmaz Tiebe! Talk to her if you are looking for a home for your paper or about scientific publishing. @EMBOevents @EMBOPress

[Hatoon @Hatoon_Bkeerah]

Very excited to share our recent research exploring the role of #FABP4 in modulating #SARSCoV2

Thank you to all my colleagues @gshlab, to @ghotamis and all our collaborators.
#metabolism #virology #infectiousdisease

[EMBO Mol. Medicine @EmboMolMed]

Online today ➡️#MicrobialMetabolites tune #amygdala neuronal hyperexcitability and #anxiety -linked behaviors.

By W. Yu, Y. Xiao, S. Pettersson, H.S. Je & colleagues @dukenus

🗞️https://t.co/jErmbcyPSh

[EMBO Mol. Medicine @EmboMolMed]

Exploiting #MetabolicVulnerability in #glioblastoma using a brain-penetrant drug with a safe profile

By @audrey_burban, @AndreasBikfalvi, @Thomas_Daubon, @SharanekAhmad & colleagues @Inserm & Bordeaux University

➡️https://t.co/WpPJN8tAcZ

[EMBO Mol. Medicine @EmboMolMed]

An AI-assisted morphoproteomic approach is a supportive tool in #esophagitis -related #PrecisionMedicine

By S. Mattern, S. Singer & colleagues at Tübingen University

➡️https://t.co/mZSZ4riZv0

[EMBO Mol. Medicine @EmboMolMed]

📢Review by K. Nadeau & colleagues at Harvard T. H. Chan School of Public Health 👉 #Exposomics: a review of methodologies, applications, & future directions in #MolecularMedicine

https://t.co/TwYd4LnTI5

[EMBO Mol. Medicine @EmboMolMed]

Review by M. Moll & D. Baumjohann @UniklinikBonn
➡️Boosting human immunology: harnessing the potential of immune organoids.

🗞️https://t.co/AXIDfhdkXP

[EMBO Mol. Medicine @EmboMolMed]

"Improving the odds of survival: transgenerational effects of infections"

👉Read the review by V. Spanou, T. Andriopoulou, E. Giamarellos-Bourboulis & M. Neteai at University of Athens & @radboudumc

🗞️https://t.co/5RfxDutcFS